BASF's November 23 Capital Markets Day Becomes the Real Test of Its Upgraded Guidance

BASF shareholders have a date circled: November 23, when the chemicals group holds its Capital Markets Day. That appearance now carries more weight than usual, because it arrives just as the company's improved earnings outlook collides with a sharply risk-averse market.

The stock was caught in the downdraft on Tuesday, shedding 2.5% as a worldwide selloff in AI and semiconductor names rippled through the DAX. Reuters reported that losses in US and Asian technology shares prompted investors to pull back from the German benchmark index, with BASF named among the index's decliners. The pressure is not company-specific — but it complicates the story management wants to tell.

Guidance Raised, and the Bar With It

Roughly a week ago, BASF lifted its full-year 2026 forecast for EBITDA before special items to a range of EUR 7.4 billion to EUR 7.8 billion, up from the EUR 6.9 billion to EUR 7.7 billion it had previously guided. That new corridor is now the yardstick against which every subsequent management statement will be measured.

The upgrade rests on a solid third quarter. Sales climbed 14% year on year to EUR 16.4 billion, while EBITDA before special items rose 15% to EUR 1.6 billion. Revenue and operating profit therefore moved in the same direction — a combination that underpins the constructive case for the stock.

What matters for investors is less the isolated quarterly figure than whether the momentum can be sustained. A higher earnings expectation works in BASF's favor only if the company can demonstrate that the improved trajectory is durable, and the Capital Markets Day offers the scheduled occasion to do exactly that.

Buybacks and a Design Award Round Out the Picture

Alongside the earnings news, BASF disclosed on Monday that it had repurchased 355,128 of its own shares during the period from October 26 through October 30 inclusive. Since the program began on August 3, the company had bought back a total of 7,595,230 shares through the end of October.

There was also recognition for a joint automotive project. BASF, Toyota and Vuteq received the SPE Automotive Innovation Grand Award for the thermoplastic truck bed of the 2026 Toyota Tacoma, a project that also took the prize in the body exterior category.

On the portfolio front, the sale of BASF's Palatal business in Chile has been agreed contractually. Completion remains subject to customary closing conditions and regulatory approvals — meaning the transaction is a future milestone rather than a closed chapter, and the earnings forecast remains the more immediate gauge of operating confidence.

Two Scenarios, One Deadline

The bullish reading hinges on management backing up the raised outlook with convincing detail. If BASF can do so, investors may be willing to weight operating progress more heavily than the drag from the broader market. The constructive case assumes the earnings path holds; the cautious one starts from the very fact that expectations have risen.

Should earnings momentum fade, confidence in the full-year target could come under strain, forcing shareholders to reprice what has so far been a positive operating run. And for as long as the broad selloff keeps risk appetite subdued, even a confirmed company forecast may deliver only a limited share-price impulse. Investors thus find themselves caught between improving fundamentals and a weak market mood.

The decision in front of them is straightforward: back the durability of the operating improvement, or wait for further confirmation before committing. Either way, the answer should arrive in Frankfurt on November 23.